Report: Bayer contemplates sale of blood glucose meter business

This just in: Bayer is reportedly talking with potential buyers of its blood glucose meters business.

Naturally, no one is commenting on the record. But Reuters reports the story, based on "two people familiar with the matter." (Guess away as to who they are.) According to those sources, the German drugmaker has apparently held talks with companies interested in buying its diabetes care unit. That division isn't small potatoes, either, as it generates about $1.3 billion in annual sales.

Bayer, for its part, wants to grow in other areas and the diabetes division doesn't offer the all-important "synergies" with its other divisions, according to the story. That means a device firm seeking to boost its presence in the diabetes sector, a growing business if there ever was one, has everything to gain. More coming soon, no doubt.

- read the Reuters story

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.